New Colombia Resources Inc fka NEWC

[quipu]

Allone the cannabis business should be worth much more than the current market value.

Do not forget : New Colombia Resources Inc. and Cannabis Science , Inc. work together. And CBIS has a Market Value of $ 56,710,402 at / o 21 November 2014.
http://www.otcmarkets.com/stock/CBIS/profile
and has no revenue!
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10315102

Read this again:

CORAL SPRINGS, Florida, November 5, 2014--(PR Newswire)--
http://www.digitaljournal.com/pr/2310497
„…
Cannabis industry forecasts billions in revenue as United States moves towards legalization and MMJ Companies focus on new plans, joint ventures and development of innovative Marijuana products.  Companies in Focus Today are: New Colombia Resources, Inc. (OTCQB: NEWC), Neutra Corp. (OTC: NTRR), Creative Edge Nutrition, Inc. (OTC: FITX), Tauriga Sciences, Inc. (OTC: TAUG) and Cannabis Science, Inc. (OTC: CBIS).

New Colombia Resources, Inc. (OTCQB: NEWC) ("New Colombia or the Company"), a U.S. company with coal and other resource assets in Colombia, is pleased to announce plans to spin out its Sannabis S.A.S medical hemp based products company and create an independent U.S. traded reporting publicly traded company. John Campo, President, stated: "Our management team is focused on our core business of developing company coal reserves and industrial aggregate operations. By allowing Sannabis SAS to become an independent public company it will be able to develop its own medical based management team. Additionally Sannabis will have one mission the development of its innovative medical products based on scientific research using unique strains of Cannabis manufactured on the TOEZ Indian Reservation in Colombia. The Company plans to issue shares of Sannabis S.A.S. as a dividend to Shareholders.
Read the full NEWC press release at http://www.financialnewsmedia.com/profiles/newc.html
After the spinoff Sannabis S.A.S. will operate as an independent company and develop its own medical research staff and funding to further the commercialization of its products.  Sannabis S.A.S. aims to become the first company to legally import hemp and medical marijuana products to the U.S. from Colombia. Operations will include patent applications, obtaining medical approvals, and further research and product development.  Sannabis SAS believes that the specific strain of hemp being produced on the TOEZ Indian reservation may creates a unique medical opportunity for many people who may find benefit from various hemp based product derivates. 
…
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting is very pleased with the laboratory analytical reports it recently received. The testing of the cannabis harvested using EU certified as well as its own unique strains produced end results indicating that whole extracts to be produced will contain upward of 20% CBD and less than 10% THC. Furthermore, other unique identifiers are present that require multiple authentications based on their significant nature. These numbers are significant based on usage information and expected treatment regimes for many of the Company targeted ailments. The Company continues investigating both its unique cannabinoid strains as well as promising strains from around the world for multiple pre-clinical drug development programs targeting Cancer, Neurological Disorders, and a few other targeted critical ailments to be announced. „

and this:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108200778